Why ALZN? Alzamend Neuro, Inc. Analysis, Price & AI Insights | Whystock
ALZN
$1.12-0.02 (-1.75%)
Market ClosedLast close May 1
Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders.